The regulatory environment workstream is trying to maximise innovative processes by highlighting existing regulatory flexibility and the positive UK regulatory landscape to industry.
As part of its programme of work, the Medicines Manufacturing Industry Partnership (MMIP) seeks to ensure that the UK has an adaptive workforce with relevant skills to sustain the future requirements of the UK medicines manufacturing industry.
The supply chain workstream seeks to deliver capable and connected infrastructure, building understanding of medicines manufacturing supply chains, identifying opportunities to maximise supply and fostering non-competitive sector collaboration.
The technology workstream seeks to understand and pursue the future needs of the medicines manufacturing industry.
The Knowledge Transfer Network (KTN) have created a tool which aims to provide a visual dynamic representation of the UK Medicines Manufacturing Innovation Landscape.